Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ: MGNX )

2.910 +0.050 (+1.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy... 
Via Benzinga
Why Shares of MacroGenics Climbed Thursday
The cancer-focused biotech delivered a strong earnings report. 
Via The Motley Fool
Macrogenics's Return On Capital Employed Insights
Via Benzinga
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
MGNX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
The Latest Analyst Ratings for Macrogenics
Via Benzinga
7 Analysts Have This to Say About Macrogenics
Via Benzinga
Expert Ratings for Macrogenics
Via Benzinga
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Shares of MacroGenics Jumped Thursday
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients
Via Benzinga
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
From MacroGenics, Inc.
Via GlobeNewswire
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS